These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15515421)

  • 21. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
    Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intra-articular treatment of arthritides and activated osteoarthritis with the 5-HT3 receptor antagonist tropisetron. A double-blind study compared with methylprednisolone.
    Samborski W; Stratz T; Mackiewicz S; Müller W
    Scand J Rheumatol Suppl; 2004; 119():51-4. PubMed ID: 15515415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of tropisetron, a 5-HT3 receptor antagonist, on analgesia and nausea after intrathecal morphine.
    Pitkänen MT; Niemi L; Tuominen MK; Rosenberg PH
    Br J Anaesth; 1993 Nov; 71(5):681-4. PubMed ID: 8251280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of fibromyalgia with tropisetron, a 5HT3 serotonin antagonist: a pilot study.
    Papadopoulos IA; Georgiou PE; Katsimbri PP; Drosos AA
    Clin Rheumatol; 2000; 19(1):6-8. PubMed ID: 10752491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tropisetron (Navoban) in the control of nausea and vomiting induced by combined cancer chemotherapy in children.
    Ozkan A; Yildiz I; Yüksel L; Apak H; Celkan T
    Jpn J Clin Oncol; 1999 Feb; 29(2):92-5. PubMed ID: 10089950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of tropisetron on circulating catecholamines and other putative biochemical markers in serum of patients with fibromyalgia.
    Höcherl K; Färber L; Ladenburger S; Vosshage D; Stratz T; Müller W; Grobecker H
    Scand J Rheumatol Suppl; 2000; 113():46-8. PubMed ID: 11028831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An open, randomized study to compare the efficacy and tolerability of tropisetron with that of a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis.
    Sorbe B; Hallén C; Frankendal B
    Cancer Chemother Pharmacol; 1994; 33(4):298-302. PubMed ID: 8281622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Local treatment of periarthropathies with the 5-HT3-receptor-antagonist tropisetron].
    Stratz T; Stauber A; Müller W
    Z Orthop Ihre Grenzgeb; 2002; 140(4):394-8. PubMed ID: 12183788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The 5-HT3 blockers in the treatment of the primary fibromyalgia syndrome: a 10-day open study with Tropisetron at a low dose.
    Samborski W; Stratz T; Lacki JK; Klama K; Mennet P; Müller W
    Mater Med Pol; 1996; 28(1):17-9. PubMed ID: 9088121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of tropisetron on the serum substance P levels in fibromyalgia patients.
    Stratz T; Fiebich B; Haus U; Müller W
    Scand J Rheumatol Suppl; 2004; 119():41-3. PubMed ID: 15515412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized double-blind placebo-controlled study of tropisetron in the treatment of outpatients with generalized anxiety disorder.
    Lecrubier Y; Puech AJ; Azcona A; Bailey PE; Lataste X
    Psychopharmacology (Berl); 1993; 112(1):129-33. PubMed ID: 7871001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tropisetron for the prevention of postoperative nausea and vomiting in women undergoing gynecologic surgery.
    Alon E; Kocian R; Nett PC; Koechli OR; Baettig U; Grimaudo V
    Anesth Analg; 1996 Feb; 82(2):338-41. PubMed ID: 8561338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
    Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The influence of depression on the effect of Tropisetron in the therapy of fibromyalgia].
    Stratz T; Varga B; Müller W
    Z Rheumatol; 2003 Feb; 62(1):42-5. PubMed ID: 12624803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of tropisetron on vomiting during patient-controlled analgesia in children.
    Allen D; Jorgensen C; Sims C
    Br J Anaesth; 1999 Oct; 83(4):608-10. PubMed ID: 10673878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose comparison of tropisetron (Navoban) 5 mg and 10 mg orally in the prophylaxis of dacarbazine-induced nausea and emesis.
    Garbe C; Drechsler S; Fiedler H; Tilgen W; Landthaler M; Schroeder K; Kuehne KH; Faerber L
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):12-6. PubMed ID: 9113121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The anti-emetic efficacy and tolerability of tropisetron in patients conditioned with high-dose chemotherapy (with and without total body irradiation) prior to bone marrow transplantation.
    Or R; Drakos P; Nagler A; Naparstek E; Kapelushnik J; Cass Y
    Support Care Cancer; 1994 Jul; 2(4):245-8. PubMed ID: 8087443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripherally administered serotonin 5-HT3 receptor antagonists reduce inflammatory pain in rats.
    Giordano J; Rogers LV
    Eur J Pharmacol; 1989 Oct; 170(1-2):83-6. PubMed ID: 2612565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimal combination therapy with tropisetron in 445 patients with incomplete control of chemotherapy-induced nausea and vomiting.
    Hulstaert F; Van Belle S; Bleiberg H; Canon JL; Dewitte M; Buyse M; De Keyser P; Westelinck KJ
    J Clin Oncol; 1994 Nov; 12(11):2439-46. PubMed ID: 7964961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [5-HT3 receptor antagonist als analgetics in rheumatic diseases].
    Müller W; Fiebich BL; Stratz T
    Z Rheumatol; 2006 Oct; 65(6):546, 548-52. PubMed ID: 16450149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.